Peak Pharmaceuticals, Inc. announced that it will receive $318,500 in funding on April 24, 2023. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | +29.35% | -.--% | +200.58% |
1st Jan change | Capi. | |
---|---|---|
+200.58% | 98.81M | |
+10.29% | 3,082B | |
+8.12% | 84.92B | |
+5.55% | 78.23B | |
-13.73% | 54.06B | |
+19.98% | 45.87B | |
-24.43% | 46.79B | |
+21.26% | 42.65B | |
+60.27% | 37.28B | |
-9.36% | 24.89B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. announced that it expects to receive $0.3185 million in funding